Subgroup | HR (95% CI) | Heterogeneity I2 (%), P |
---|---|---|
Indicators: | ||
MLXIPL | 1.88 (1.02, 3.47) | NA |
GLUT4 | 1.44 (0.40, 5.20) | NA |
PKM2 | 1.93 (1.70, 2.18) | I2 = 0.0%, P = 0.704 |
MAP17 | 1.64 (1.36, 1.98) | NA |
PFKFB3 | 2.45 (1.09, 5.52) | NA |
STMN1 | 2.57 (1.43, 4.65) | I2 = 49.6%, P = 0.138 |
PGM1 | 1.71 (1.11, 2.63) | NA |
MCT4 | 1.64 (1.30, 2.07) | I2 = 0.0%, P = 0.755 |
GLUT1 | 1.47 (1.05, 2.05) | I2 = 44.1%, P = 0.181 |
CDK1 | 1.99 (0.37, 10.70) | NA |
HK-2 | 2.12 (1.66, 2.71) | I2 = 0.0%, P = 0.604 |
CA9 | 2.26 (1.47, 3.47) | I2 = 41.1%, P = 0.165 |
Homer1 | 1.66 (0.78, 3.54) | NA |
ASCT2 | 1.76 (1.12, 2.76) | NA |
LDHB | 0.66 (0.46, 0.93) | NA |
TRIM35 | 0.60 (0.39, 0.92) | NA |
PGK-1 | 3.09 (1.31, 7.29) | NA |
GLUT2 | 1.65 (0.86, 3.20) | I2 = 0.0%, P = 0.347 |
Region: | ||
China | 1.66 (1.43, 1.94) | I2 = 67.4%, P < 0.001 |
Japan | 2.37 (1.44, 3.88) | I2 = 28.1%, P = 0.234 |
Germany | 1.95 (1.34, 2.83) | I2 = 0.0%, P = 0.493 |
Taiwan | 2.70 (1.64, 4.45) | I2 = 21.5%, P = 0.280 |
South Korea | 2.19 (1.14, 4.20) | NA |
Hong Kong | 1.75 (1.02, 3.00) | NA |
US | 1.86 (1.23, 2.82) | NA |
Sample: | Â | Â |
Tissue | 1.80 (1.57, 2.05) | I2 = 60.3%, P < 0.001 |
Serum | 1.82 (1.29, 2.56) | I2 = 0.0%, P = 0.704 |
Detection method: | Â | Â |
IHC | 1.80 (1.56, 2.07) | I2 = 63.4%, P < 0.001 |
qRT-PCR | 1.80 (1.30, 2.50) | I2 = 0.0%, P = 0.885 |
IF | 2.45 (1.09, 5.52) | NA |
ELISA | 1.69 (1.02, 2.81) | NA |